Contrast

Contact

Share

MyChart

Help

L+M Hospital funds Narcan supply for local communities

Tuesday, October 3, 2017

New London, CT – October 3, 2017 – Lawrence + Memorial Hospital today announced it was providing funding for a supply of Narcan, the drug used to treat victims of an opioid overdose, to 11 local communities.

Municipalities and governments receiving the supply from hospital funding include East Lyme, Groton City, Groton Long Point, Groton Town, Ledyard, Mashantucket Pequot Tribal Nation, Mohegan Tribal Nation, Montville, New London, Stonington and Waterford.

The hospital is investing approximately $10,000 for this effort.

“Of great concern to us all – leaders of our cities and towns and leaders of our organization – is the opioid epidemic,” said Patrick L. Green, president and chief executive officer of L+M Hospital. “By providing the funding to supply these municipalities with Narcan, we are one step closer to preventing another opioid death. This will allow area first responders to immediately begin potentially life-saving treatment in the field.”

While the crisis spiked at L+M Hospital in 2016, it has seen a significant increase in heroin-specific cases in the last few years. In 2014, the hospital treated a total of 74 heroin cases. That number jumped to 111 in 2015 before spiking to 165 in 2016. For 2017, the hospital has treated 71 heroin-specific cases (through July).

“This remains a serious problem for all of us in southeastern Connecticut. We can’t wait for a perfect solution to be put into place,” Green said. “Every step is a positive step. While we hope and pray for an end to this crisis, there is a lot of work to be done. My hope is that our partnership with these communities and with our local legislative delegation, as well as our congressional delegation, will demonstrate that we are fighting this epidemic together – as one community.”

This is the second time the hospital has provided funding for Narcan. Last year, after the start of the crisis in this area, it provided resources to a smaller number of communities. However, with the ongoing opioid crisis, as well as the budgetary challenges facing municipalities, the list of communities was expanded this year.

Lawrence + Memorial Hospital, a member of Yale New Haven Health, is a non-profit, 280-bed general and acute care hospital providing patient care to medical, surgical, pediatric, psychiatric and obstetrical patients in southeastern Connecticut and southern Rhode Island since 1912. Lawrence + Memorial offers cardiac acute, step-down and rehabilitation programs and is the only eastern Connecticut hospital that performs emergency and elective angioplasty. www.lmhospital.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.

Media Contact

Fiona Phelan

203-780-1993
860-271-4634

[email protected]